share_log

Jiangsu Hengrui Medicine Gets US FDA Approval for Anesthetic; Shares Rise 4%

江蘇恒瑞医学が麻酔薬の米国FDA承認を取得、株価は4%上昇

MT Newswires ·  07/03 02:07

Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.

これらの内容は、情報提供及び投資家教育のためのものであり、いかなる個別株や投資方法を推奨するものではありません。 更に詳しい情報
    コメントする